317 related articles for article (PubMed ID: 34120224)
1. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
[TBL] [Abstract][Full Text] [Related]
2. The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients.
Leinert E; Lukac S; Schwentner L; Coenen A; Fink V; Veselinovic K; Dayan D; Janni W; Friedl TWP
Surg Oncol; 2024 Feb; 52():102016. PubMed ID: 38056112
[TBL] [Abstract][Full Text] [Related]
3. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
Peppe A; Wilson R; Pope R; Downey K; Rusby J
Breast; 2017 Oct; 35():104-108. PubMed ID: 28704697
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?
Morgan C; Stringfellow TD; Rolph R; Kovacs T; Kothari A; Pinder SE; Hamed H; Sever AR
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):522-526. PubMed ID: 31740186
[TBL] [Abstract][Full Text] [Related]
5. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793
[TBL] [Abstract][Full Text] [Related]
6. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.
Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S
Br J Radiol; 2021 Nov; 94(1127):20210788. PubMed ID: 34491822
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapy.
İriağaç Y; Karaboyun K; Çavdar E; Avci O; Kurtoğlu Özçağlayan Tİ; Öznur M; Ozkan Gurdal S; Şeber ES
Neoplasma; 2022 May; 69(3):741-746. PubMed ID: 35471979
[TBL] [Abstract][Full Text] [Related]
8. The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
Helfgott R; Mittlböck M; Miesbauer M; Moinfar F; Haim S; Mascherbauer M; Schlagnitweit P; Heck D; Knauer M; Fitzal F
Eur J Surg Oncol; 2019 Apr; 45(4):538-543. PubMed ID: 30366878
[TBL] [Abstract][Full Text] [Related]
9. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Garcia-Tejedor A; Fernandez-Gonzalez S; Ortega R; Gil-Gil M; Perez-Montero H; Fernandez-Montolí E; Stradella A; Recalde S; Soler T; Petit A; Bajen MT; Benitez A; Guma A; Campos M; Pla MJ; Martinez E; Laplana M; Pernas S; Perez-Sildekova D; Catala I; Ponce J; Falo C
Breast Cancer Res Treat; 2021 Feb; 185(3):657-666. PubMed ID: 33068198
[TBL] [Abstract][Full Text] [Related]
10. Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
Wellington J; Sanders T; Mylander C; Alden A; Harris C; Buras R; Tafra L; Liang W; Stelle L; Rosman M; Jackson RS
Ann Surg Oncol; 2018 Aug; 25(8):2271-2278. PubMed ID: 29868976
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer.
Hotton J; Salleron J; Henrot P; Buhler J; Leufflen L; Rauch P; Marchal F
Breast Cancer Res Treat; 2020 Oct; 183(3):639-647. PubMed ID: 32737710
[TBL] [Abstract][Full Text] [Related]
13. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy.
Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A
Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050
[TBL] [Abstract][Full Text] [Related]
14. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
15. Does use of axillary ultrasound in clinically node-negative patients receiving neo-adjuvant systemic therapy for breast cancer lead to surgical overtreatment?
Horwood C; Ma N; Hayek J; Terando AM; Agnese DM; Grignol V
Breast J; 2020 Feb; 26(2):120-124. PubMed ID: 31435992
[TBL] [Abstract][Full Text] [Related]
16. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Boughey JC; Ballman KV; Hunt KK; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Le-Petross HT
J Clin Oncol; 2015 Oct; 33(30):3386-93. PubMed ID: 25646192
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy: A prospective study.
Najim O; Dockx Y; Huyghe I; van den Wyngaert T; Papadimitriou K; Tjalma WAA; Huizing MT
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():108-111. PubMed ID: 30145524
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer patients with a negative axillary ultrasound may have clinically significant nodal metastasis.
Keelan S; Heeney A; Downey E; Hegarty A; Roche T; Power C; Mhuircheartaigh NN; Duke D; Kerr J; Hambly N; Hill A
Breast Cancer Res Treat; 2021 Jun; 187(2):303-310. PubMed ID: 33837870
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of magnetic resonance imaging to evaluate axillary lymph node status in breast cancer patients receiving neoadjuvant chemotherapy.
Bansal GJ; Jaipal A; Wu GKC; Syed A
Br J Radiol; 2023 Mar; 96(1143):20220904. PubMed ID: 36607272
[TBL] [Abstract][Full Text] [Related]
20. Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant.
Cox K; Dineen N; Taylor-Phillips S; Sharma N; Harper-Wynne C; Allen D; Weeks J; Chalmers R; Akolekar D; Burcombe R; Jyothirmayi R; Sever A
Breast Cancer Res Treat; 2021 Jan; 185(2):413-422. PubMed ID: 33029707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
